TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7659806

Group type: EXPERIMENTAL
Intervention: Pharmacological approach (ocitocic conduction and peridural anesthesia)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Spontaneous evolution
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups (pharmacological and spontaneous)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Active management
Number of subjects: 81
Study: 3303297

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 52

Group type: COMPARATOR
Intervention: NSAID continued
Number of subjects: 52

Group type: COMPARATOR
Intervention: NSAID withdrawn
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 52
Study: 31493104

Group type: EXPERIMENTAL
Intervention: INFLATE group using a two-channel TENStem eco basic device with two electrodes for pain control during the biopsy.
Number of subjects: 138

Group type: COMPARATOR
Intervention: TRUS-PNB group receiving 60 mg lidocaine gel intrarectally and infiltration of a prilocaine and bupivacaine mixture (5 mL of 2% prilocaine + 5 mL of 0.25% bupivacaine).
Number of subjects: 138
Study: 27899807

Group type: EXPERIMENTAL
Intervention: Pre‐portioned Foods Group
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard Advice Group
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Portion Selection Group
Number of subjects: 186
Study: 25213774

Group type: EXPERIMENTAL
Intervention: AMG 811 (180 mg SC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AMG 811
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estimated free serum IFN‐γ concentration levels
Number of subjects: 0
Study: 22715020

Group type: EXPERIMENTAL
Intervention: LigaSure Precise (LP)
Number of subjects: 199

Group type: COMPARATOR
Intervention: FOCUS Shears (FS)
Number of subjects: 199
Study: 21676002

Group type: EXPERIMENTAL
Intervention: Alcohol mixed with energy drink (AmED)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 56
Study: 18830192

Group type: EXPERIMENTAL
Intervention: IV infusion of 2 g of magnesium sulfate
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 16920438

Group type: EXPERIMENTAL
Intervention: New proximal aortic anastomotic device
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 24
Study: 14764128

Group type: EXPERIMENTAL
Intervention: Duloxetine 40 mg twice daily for 12 weeks
Number of subjects: 458

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 458
Study: 11348827

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis simulator model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mannequin simulator model
Number of subjects: 0
Study: 9151061

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no drug regimen specified)
Number of subjects: 0
Study: 8423888

Group type: EXPERIMENTAL
Intervention: Bromocriptine (Br) monotherapy
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Levodopa (LD) monotherapy
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination therapy (Br and LD)
Number of subjects: 22
Study: 3434885

Group type: EXPERIMENTAL
Intervention: Isoflurane at a concentration of 1 MAC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Halothane at a concentration of 1 MAC
Number of subjects: 40
Study: 31542993

Group type: EXPERIMENTAL
Intervention: Gastroschisis (DVM assessment)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Gastroschisis (amniocyte vacuolization assessment)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group with DVM
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group with normal villous morphology
Number of subjects: 23
Study: 30527103

Group type: EXPERIMENTAL
Intervention: Less tight control of maternal blood pressure
Number of subjects: 683

Group type: COMPARATOR
Intervention: Tight control of maternal blood pressure
Number of subjects: 683
Study: 26977100

Group type: EXPERIMENTAL
Intervention: Statistical approach to sampling size for data validation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical techniques for data validation
Number of subjects: 0
Study: 24415114

Group type: EXPERIMENTAL
Intervention: TREATED (n=32)
Number of subjects: 49

Group type: COMPARATOR
Intervention: NOT TREATED (n=17)
Number of subjects: 49
Study: 22428455

Group type: EXPERIMENTAL
Intervention: Sustained trunk flexion with a load (5, 10, and 15 kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sustained trunk flexion with a load (15 kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sustained trunk flexion while holding a load
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unloaded trunk flexion
Number of subjects: 12
Study: 19400981

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (duration: 4 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated patients with major depression
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (1-2 weeks)
Number of subjects: 24
Study: 18046432

Group type: EXPERIMENTAL
Intervention: Aggressive strategy targeting SBP <130 mm Hg
Number of subjects: 1111

Group type: COMPARATOR
Intervention: Conventional strategy targeting SBP <140 mm Hg
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: Composite pool of pre-specified fatal and non-fatal events
Number of subjects: 1111
Study: 11777998

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 397

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 397
Study: 9606433

Group type: EXPERIMENTAL
Intervention: Functional Magnetic Resonance Imaging (fMRI)
Number of subjects: 0
Study: 7761011

Group type: EXPERIMENTAL
Intervention: Peridural morphine hydrochloride (0.5 mg/kg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sublingual buprenorphine (0.4 mg)
Number of subjects: 44
Study: 3051332

Group type: EXPERIMENTAL
Intervention: Glycosaminoglycan polysulphate (GAGPS) treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 30
Study: 31303296

Group type: EXPERIMENTAL
Intervention: Coaching-based implementation of the WHO Safe Childbirth Checklist
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 28545514

Group type: EXPERIMENTAL
Intervention: Home-based BP telemonitor with GSM module and unlimited data plan, app for personal healthcare record access, personalized lifestyle coaching, and proficiency training.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coordinated PCP-cardiologist care with data sharing via CareLinker website.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 0
Study: 25989216

Group type: EXPERIMENTAL
Intervention: Mangiferin (150 mg/day)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 23865902

Group type: EXPERIMENTAL
Intervention: Suture flap fixation
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Compression dressing
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Early drain removal
Number of subjects: 161

Group type: COMPARATOR
Intervention: Conventional method of closed suction drains
Number of subjects: 161
Study: 21304153

Group type: EXPERIMENTAL
Intervention: OPLAC™
Number of subjects: 60

Group type: COMPARATOR
Intervention: LMA Classic™
Number of subjects: 60
Study: 18638711

Group type: COMPARATOR
Intervention: Western medicine therapy (WM) including voltaren extended action tablet, methotrexate, and sulfasalazine
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine therapy (CM) including Glucosidorum Tripterygll Totorum tablet and Yishen Juanbi Tablet
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine therapy (CM)
Number of subjects: 396
Study: 17022792

Group type: EXPERIMENTAL
Intervention: Integrated treatment (IT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 50
Study: 15072604

Group type: EXPERIMENTAL
Intervention: Bicalutamide monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bicalutamide as immediate therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined androgen blockade (CAB) with bicalutamide
Number of subjects: 0
Study: 11109422

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: HCT/amiloride 50 mg/5 mg
Number of subjects: 31
Study: 9182081

Group type: EXPERIMENTAL
Intervention: 100 mg oral flosequinan after 10 days of treatment
Number of subjects: 18
Study: 8372849

Group type: EXPERIMENTAL
Intervention: Two screening sonograms
Number of subjects: 15530

Group type: COMPARATOR
Intervention: Conventional obstetric care
Number of subjects: 15530
Study: 31452431

Group type: EXPERIMENTAL
Intervention: Pinloc
Number of subjects: 439

Group type: COMPARATOR
Intervention: Hansson pins
Number of subjects: 439
Study: 30419911

Group type: EXPERIMENTAL
Intervention: Red light phototherapy (RLPT), 10 min/time, 2 times/day until the end of radiotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine daily care during radiotherapy treatment (Control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Red light phototherapy (RLPT)
Number of subjects: 60
Study: 26453951

Group type: EXPERIMENTAL
Intervention: Comprehensive self-management (CSM) program combining cognitive behavioral therapy with relaxation and dietary strategies; 9 sessions (1 hour each) over 13 weeks
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Comprehensive self-management (CSM) program
Number of subjects: 81
Study: 24700351

Group type: EXPERIMENTAL
Intervention: Cognitive Interview (CI)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Free recall
Number of subjects: 98
Study: 21780085

Group type: EXPERIMENTAL
Intervention: Aluminum chloride (20 mM) injections daily from E12 to E15
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aluminum chloride (2 mM) injections daily from E12 to E15
Number of subjects: 0
Study: 21433319

Group type: EXPERIMENTAL
Intervention: Prostamol Uno (PU) 320 mg/day for 36 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 50
Study: 18959779

Group type: EXPERIMENTAL
Intervention: Eudorlin extra
Number of subjects: 3

Group type: COMPARATOR
Intervention: Nurofen forte
Number of subjects: 3

Group type: COMPARATOR
Intervention: Migränin
Number of subjects: 3
Study: 17153708

Group type: EXPERIMENTAL
Intervention: Modified endocystectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Closed total pericystectomy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study: 14614416

Group type: EXPERIMENTAL
Intervention: 1-week activation with soft material
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 1-week activation with hard material
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 2-week activation with soft material
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 2-week activation with hard material
Number of subjects: 51
Study: 11061582

Group type: EXPERIMENTAL
Intervention: Sumatriptan (50 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Rizatriptan (10 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Zolmitriptan (2.5 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8807731

Group type: EXPERIMENTAL
Intervention: Nonionic contrast media (NICM) iopamidol 370
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ionic contrast media (ICM) ioxaglate
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no contrast material)
Number of subjects: 34
Study: 1557928

Group type: EXPERIMENTAL
Intervention: Two-component pertussis vaccine (containing pertussis toxoid and filamentous haemagglutinin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monocomponent pertussis toxoid vaccine
Number of subjects: 0
Study: 3891278

Group type: EXPERIMENTAL
Intervention: Netilmicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 0
Study: 30653043

Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty
Number of subjects: 219

Group type: COMPARATOR
Intervention: Screw Fixation
Number of subjects: 219
Study: 29968397

Group type: EXPERIMENTAL
Intervention: 30 mg/day of baclofen
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 75 mg baclofen
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 26050104

Group type: EXPERIMENTAL
Intervention: Itolizumab 0.2 mg/kg weekly with methotrexate
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Itolizumab 0.4 mg/kg weekly with methotrexate
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Itolizumab 0.8 mg/kg weekly with methotrexate
Number of subjects: 70

Group type: COMPARATOR
Intervention: Methotrexate alone
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Itolizumab with methotrexate
Number of subjects: 70
Study: 24737255

Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Caffeine 400 mg
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 22218013

Group type: EXPERIMENTAL
Intervention: Consuming breakfast
Number of subjects: 21

Group type: COMPARATOR
Intervention: Omitting breakfast
Number of subjects: 21
Study: 20142538

Group type: EXPERIMENTAL
Intervention: Fixed-combination latanoprost-timolol (FCLT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 0

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 0
Study: 17356043

Group type: EXPERIMENTAL
Intervention: IGF((low)) group (n = 70)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: IGF((high)) group (n = 68)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Conventional GH dose of 40 microg/kg/d (n = 34)
Number of subjects: 172
Study: 15699378

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day administered three times daily (TID)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day administered twice daily (BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day administered TID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day administered BID
Number of subjects: 0
Study: 11889661

Group type: EXPERIMENTAL
Intervention: Clonazepam (0.5 mg/night)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine (10 mg/night)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 10457249

Group type: EXPERIMENTAL
Intervention: Foot massage and analgesia post-operatively
Number of subjects: 59

Group type: COMPARATOR
Intervention: Analgesia post-operatively
Number of subjects: 59
Study: 7842192

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: No inhaled corticosteroids (Control)
Number of subjects: 0
Study: 2121114

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (5 mg intravenous infusion for 60 minutes)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution (control)
Number of subjects: 8
Study: 650201

Group type: EXPERIMENTAL
Intervention: Marijuana extract cookies (0.3 mg/kg delta‐9‐tetrahydrocannabinol)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo conditions
Number of subjects: 16
Study: 31566486

Group type: EXPERIMENTAL
Intervention: Concurrent laparoscopic cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Separate laparoscopic cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 56
Study: 28619269

Group type: EXPERIMENTAL
Intervention: Anterior approach (ACDF, ACCF, HDF)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Laminoplasty
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Anterior approach
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 252
Study: 26314809

Group type: EXPERIMENTAL
Intervention: Talking Card (customized audio-recorded instructions)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 64
Study: 23815538

Group type: EXPERIMENTAL
Intervention: Patients with OSA
Number of subjects: 57

Group type: COMPARATOR
Intervention: Hypertensive controls without OSA
Number of subjects: 57
Study: 21632099

Group type: EXPERIMENTAL
Intervention: Initial treatment (surgery and chemotherapy) for White patients
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Initial treatment (surgery and chemotherapy) for African-American patients
Number of subjects: 405

Group type: COMPARATOR
Intervention: Cytoreductive surgery and chemotherapy for both racial groups
Number of subjects: 405

Group type: COMPARATOR
Intervention: Multivariate analysis of factors associated with overall survival
Number of subjects: 405
Study: 19081121

Group type: EXPERIMENTAL
Intervention: Ivermectin alone (150‐200 microg/kg body weight)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Ivermectin and albendazole combination (total of 400mg)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 182
Study: 16720865

Group type: EXPERIMENTAL
Intervention: Monomeric contrast agent
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Dimeric contrast agent
Number of subjects: 895

Group type: COMPARATOR
Intervention: Control group (unenhanced CT)
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Both contrast agents
Number of subjects: 895
Study: 14581415

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus cisplatin (arm A)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (arm B)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus gemcitabine (arm C)
Number of subjects: 480
Study: 10890578

Group type: COMPARATOR
Intervention: Cerivastatin 0.8 mg after an overnight fast (8 a.m. dosing)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.8 mg with a high-fat breakfast (8 a.m. dosing)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.8 mg with evening meal (6 p.m. dosing, low-fat)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cerivastatin 0.8 mg 4 hours after dinner (10 p.m. dosing)
Number of subjects: 24
Study: 8689651

Group type: EXPERIMENTAL
Intervention: Ultrafiltration (UF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no UF)
Number of subjects: 18
Study: 1533060

Group type: EXPERIMENTAL
Intervention: Systematic stretching maneuver
Number of subjects: 28

Group type: COMPARATOR
Intervention: Multimodal rehabilitation program
Number of subjects: 28
Study: 3158124

Group type: EXPERIMENTAL
Intervention: Kamillosan cream
Number of subjects: 161

Group type: COMPARATOR
Intervention: 0.25% hydrocortisone
Number of subjects: 161

Group type: COMPARATOR
Intervention: 5% bufexamac
Number of subjects: 161

Group type: COMPARATOR
Intervention: 0.75% fluocortin butyl ester
Number of subjects: 161
Study: 29692281

Group type: EXPERIMENTAL
Intervention: Positive Psychology self-help book (Akhtar, 2012)
Number of subjects: 115

Group type: COMPARATOR
Intervention: CBT self-help book
Number of subjects: 115
Study: 31238925

Group type: EXPERIMENTAL
Intervention: Cooled radiofrequency ablation (CRFA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intra-articular steroid (IAS) injections
Number of subjects: 0
Study: 27334135

Group type: EXPERIMENTAL
Intervention: Suprapubic drainage
Number of subjects: 160

Group type: COMPARATOR
Intervention: Transurethral catheterization (control)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study: 24778268

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT) for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Low-Intensity Training (LIT) for 12 weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both HIT and LIT
Number of subjects: 43
Study: 24240835

Group type: EXPERIMENTAL
Intervention: Serial casting
Number of subjects: 18

Group type: COMPARATOR
Intervention: Passive stretching
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison between serial casting and passive stretching
Number of subjects: 18
Study: 21810747

Group type: EXPERIMENTAL
Intervention: Intravenous mannitol (1.5 g/kg followed by 0.5 g/kg every 8 hours; n = 30)
Number of subjects: 126

Group type: COMPARATOR
Intervention: No adjunctive therapy (n = 31)
Number of subjects: 126
Study: 19417993

Group type: EXPERIMENTAL
Intervention: Standard Ni-Ti rocking chair arch wire
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 16903977

Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (stavudine and lamivudine)
Number of subjects: 0
Study: 15478147

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 109

Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 109
Study: 11525086

Group type: EXPERIMENTAL
Intervention: Thiazolidine-dione derivatives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with sulphonylurea derivatives or metformin
Number of subjects: 0
Study: 9145887

Group type: EXPERIMENTAL
Intervention: Teicoplanin 6 mg x kg(‐1) intravenously at induction of anesthesia
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Teicoplanin 12 mg x kg(‐1) intravenously at induction of anesthesia
Number of subjects: 23
Study: 8197277

Group type: EXPERIMENTAL
Intervention: Good day pharmacists
Number of subjects: 389

Group type: COMPARATOR
Intervention: Typical day pharmacists
Number of subjects: 389
Study: 3129008

Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg three times daily for 14 days
Number of subjects: 6
Study: 29844129

Group type: EXPERIMENTAL
Intervention: Binimetinib (30 mg twice a day continuous or 45 mg twice a day intermittent) with intravenous weekly paclitaxel (80 mg/m2)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Binimetinib (45 mg twice a day continuous)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Binimetinib (45 mg twice a day intermittent)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Patients with MAPK pathway-altered tumors
Number of subjects: 34
Study: 27037553

Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62